Color Study (High-Risk Breast Lesions) - Clinical Trial
Email to Participate
jennifer.plichta@duke.edu
What is the Purpose of this Study?
If you choose to join this study, you will:
- Give a saliva sample
- Have a genetic test using the Color Genomics 30 gene hereditary panel test
What is the Condition Being Studied?
Genetic Testing
Who Can Participate in the Study?
Women diagnosed with high-risk breast lesions, which include:
- Lobular carcinoma in situ (LCIS)
- Atypical ductal hyperplasia (ADH)
- Atypical lobular hyperplasia (ALH)
- Flat epithelial atypia (FEA)
- Columnar cell hyperplasia (CCH)
Age Group
Adults
What is Involved?
We are doing this study to screen women diagnosed with high-risk breast lesions for genetic mutations that may be linked to a future risk of cancer.
Study Details
Full Title
Genetic testing for women with high-risk breast lesions
Principal Investigator
Surgical Oncologist
Protocol Number
IRB:
PRO00089223
NCT:
NCT00000000
Phase
Phase
N/A
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate